Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe new screenshot exhibits the same study details with only minor visual and layout adjustments; no substantive edits to the study content or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check39 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference5%

- Check46 days agoChange DetectedCore content update includes standardizing the term to BCR-ABL1 and upgrading the revision to v3.1.0; additions introduce new identifiers (number and email addresses) with minor relevance to contact-like data.SummaryDifference0.4%

- Check60 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed; no other content changes.SummaryDifference0.3%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check74 days agoChange DetectedThe web page has updated its facility name and location details while also revising the resources related to genetic and rare diseases, specifically focusing on various types of leukemia. The previous version's resources have been significantly reduced.SummaryDifference8%

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.